Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7–30.
Article
PubMed
Google Scholar
Morice P, Leary A, Creutzberg C, Abu-Rustum N, Darai E. Endometrial cancer. Lancet. 2016;387:1094–108.
Article
PubMed
Google Scholar
Braun MM, Overbeek-Wager EA, Grumbo RJ. Diagnosis and Management of Endometrial Cancer. Am Fam Physician. 2016;93:468–74.
PubMed
Google Scholar
Hoskins WJ. Principles and practice of gynecologic oncology: Lippincott Williams & Wilkins; 2005. https://books.google.com/books?hl=en&lr=&id=KW9esgo759EC&oi=fnd&pg=PR11&dq=Hoskins+WJ.+Principles+and+Practice+of+Gynecologic+Oncology.+Lippincott+Williams+%26+Wilkins%3B+2005.&ots=SLSte8vxah&sig=Bo_yVLKbFioPSTQMCzScbSa9Z3k#v=onepage&q=Hoskins%20WJ.%20Principles%20and%20Practice%20of%20Gynecologic%20Oncology.%20Lippincott%20Williams%20%26%20Wilkins%3B%202005.&f=false.
Fader AN, Arriba LN, Frasure HE, von Gruenigen VE. Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship. Gynecol Oncol. 2009;114:121–7.
Article
PubMed
Google Scholar
Waldmann A, Eisemann N, Katalinic A. Epidemiology of malignant cervical, Corpus uteri and ovarian Tumours - current data and epidemiological trends. Geburtshilfe Frauenheilkd Georg Thieme Verlag KG. 2013;73:123–9.
Article
CAS
Google Scholar
Carlson MJ, Thiel KW, Leslie KK. Past, present, and future of hormonal therapy in recurrent endometrial cancer. Int J Women's Health. 2014;6:429–35.
Google Scholar
Okuda T, Sekizawa A, Purwosunu Y, Nagatsuka M, Morioka M, Hayashi M, et al. Genetics of endometrial cancers. Obstet Gynecol Int. 2010;2010:1–8.
Article
CAS
Google Scholar
Dunlop M. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet. 1997;6:105–10.
Article
CAS
PubMed
Google Scholar
Shai A, Segev Y, Narod SA. Genetics of endometrial cancer. Fam Cancer. 2014;13:499–505.
Article
CAS
PubMed
Google Scholar
Strafford JC. Genetic testing for lynch syndrome, an inherited cancer of the bowel, endometrium, and ovary. Rev Obstet Gynecol. 2012;5:42–9.
PubMed
PubMed Central
Google Scholar
Jones S, Stransky N, McCord CL, Cerami E, Lagowski J, Kelly D, et al. Genomic analyses of gynaecologic carcinosarcomas reveal frequent mutations in chromatin remodelling genes. Nature Communications. 2014;5:5006.
Article
CAS
PubMed
Google Scholar
Alioto TS, Buchhalter I, Derdak S, Hutter B, Eldridge MD, Hovig E, et al. A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing. Nature Communications. 2015;6:1–13.
Article
CAS
Google Scholar
Tamborero D, Gonzalez-Perez A, Perez-Llamas C, Deu-Pons J, Kandoth C, Reimand J, et al. Comprehensive identification of mutational cancer driver genes across 12 tumor types. Sci Rep. 2013;3:1–10.
Google Scholar
Meyerson M, Gabriel S, Getz G. Advances in understanding cancer genomes through second-generation sequencing. Nat Rev Genet. 2010;11:685–96.
Article
CAS
PubMed
Google Scholar
Knudson AG. Mutation and Cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA. 1971;68:820–3.
Article
PubMed
PubMed Central
Google Scholar
Saito M, Okamoto A, Kohno T, Takakura S, Shinozaki H, Isonishi S, et al. Allelic imbalance and mutations of the PTEN gene in ovarian cancer. Int. J. Cancer. 2000;85:160–5.
Article
CAS
PubMed
Google Scholar
Nomoto S, Haruki N, Tatematsu Y, Konishi H, Mitsudomi T, Takahashi T. Frequent allelic imbalance suggests involvement of a tumor suppressor gene at 1p36 in the pathogenesis of human lung cancers. Genes Chromosom Cancer. 2000;28:342–6.
Article
CAS
PubMed
Google Scholar
Zhou C-Z, Qiu G-Q, Zhang F, He L, Peng Z-H. Loss of heterozygosity on chromosome 1 in sporadic colorectal carcinoma. World J Gastroenterol. 2004;10:1431–5.
Tomlinson IPM. Two hits revisited again. J Med Genet. 2001;38:81–5.
Article
CAS
PubMed
PubMed Central
Google Scholar
Miller EM, Patterson NE, Zechmeister JM, Bejerano-Sagie M, Delio M, Patel K, et al. Development and validation of a targeted next generation DNA sequencing panel outperforming whole exome sequencing for the identification of clinically relevant genetic variants. Oncotarget. 2017;8:102033–45.
PubMed
PubMed Central
Google Scholar
Liang H, Cheung LWT, Li J, Ju Z, Yu S, Stemke-Hale K, et al. Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer. Genome Res. 2012;22:2120–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lu C, Xie M, Wendl MC, Wang J, McLellan MD, Leiserson MDM, et al. Patterns and functional implications of rare germline variants across 12 cancer types. Nat Commun. 2015;6:1–13.
CAS
Google Scholar
Kanchi KL, Johnson KJ, Lu C, McLellan MD, Leiserson MDM, Wendl MC, et al. Integrated analysis of germline and somatic variants in ovarian cancer. Nat Commun. 2014;5:1–29.
Article
CAS
Google Scholar
Stark Z, Dolman L, Manolio TA, Ozenberger B, Hill SL, Caulfied MJ, et al. Integrating Genomics into Healthcare: A Global Responsibility. Am J Human Genet. 2019;104:13–20.
Article
CAS
Google Scholar
Bastarache L, Hughey JJ, Hebbring S, Marlo J, Zhao W, Ho WT, et al. Phenotype risk scores identify patients with unrecognized Mendelian disease patterns. Science. 2018;359:1233–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Verma A, Lucas A, Verma SS, Zhang Y, Josyula N, Khan A, et al. PheWAS and beyond: the landscape of associations with medical diagnoses and clinical measures across 38,662 individuals from Geisinger. Am J Hum Genet. 2018;102:592–608.
Article
CAS
PubMed
PubMed Central
Google Scholar
Verma A, Bang L, Miller JE, Zhang Y, Lee MTM, Zhang Y, et al. Human-Disease Phenotype Map Derived from PheWAS across 38,682 Individuals. Am J Hum Genet. 2019;104:55–64.
Long B, Lilyquist J, Weaver A, Hu C, Gnanaolivu R, Lee KY, et al. Cancer susceptibility gene mutations in type I and II endometrial cancer. Gynecol Oncol. 2019;152:20–5.
Article
CAS
PubMed
Google Scholar
Carey DJ, Fetterolf SN, Davis FD, Faucett WA, Kirchner HL, Mirshahi U, et al. The Geisinger MyCode community health initiative: an electronic health record–linked biobank for precision medicine research. Genet Med. 2016;18:906–13.
Article
PubMed
PubMed Central
Google Scholar
Dewey FE, Murray MF, Overton JD, Habegger L, Leader JB, Fetterolf SN, et al. Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR study. Science. 2016;354. https://doi.org/10.1126/science.aaf6814.
McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res Cold Spring Harbor Lab. 2010;20:1297–303.
CAS
Google Scholar
Carson AR, Smith EN, Matsui H, Brækkan SK, Jepsen K, Hansen J-B, et al. Effective filtering strategies to improve data quality from population-based whole exome sequencing studies. BMC Bioinformatics. 2014;15:125.
Article
PubMed
PubMed Central
Google Scholar
Van Allen EM, Wagle N, Stojanov P, Perrin DL, Cibulskis K, Marlow S, et al. Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine. Nat Med. 2014;20:682–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Landrum MJ, Lee JM, Riley GR, Jang W, Rubinstein WS, Church DM, et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 2014;42:D980–5.
Article
CAS
PubMed
Google Scholar
McLaren W, Pritchard B, Rios D, Chen Y, Flicek P, Cunningham F. Deriving the consequences of genomic variants with the Ensembl API and SNP effect predictor. Bioinformatics. 2010;26:2069–70.
Article
CAS
PubMed
PubMed Central
Google Scholar
McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GRS, Thormann A, et al. The Ensembl variant effect predictor. Genome Biol. 2016;17:122.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536:285–91.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fu W, O’Connor TD, Jun G, Kang HM, Abecasis G, Leal SM, et al. Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants. Nature. 2013;493:216–20.
Article
CAS
PubMed
Google Scholar
Consortium GP. A global reference for human genetic variation. Nature. 2015;526:68–74.
Article
CAS
Google Scholar
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–23.
Article
PubMed
PubMed Central
Google Scholar
Schmandt RE, Iglesias DA, Co NN, Lu KH. Understanding obesity and endometrial cancer risk: opportunities for prevention. Am J Obstet Gynecol. 2011;205:518–25.
Article
PubMed
PubMed Central
Google Scholar
Basen-Engquist K, Chang M. Obesity and Cancer risk: recent review and evidence. Curr Oncol Rep. 2010;13:71–6.
Article
Google Scholar
Hamilton CA, Cheung MK, Osann K, Chen L, Teng NN, Longacre TA, et al. Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers. Br J Cancer. 2006;94:642–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Forbes SA, Bindal N, Bamford S, Cole C, Kok CY, Beare D, et al. COSMIC: mining complete cancer genomes in the catalogue of somatic mutations in Cancer. Nucleic Acids Res Narnia. 2011;39:D945–50.
Article
CAS
Google Scholar
Randall LM, Pothuri B. The genetic prediction of risk for gynecologic cancers. Gynecol Oncol. 2016;141:10–6.
Article
CAS
PubMed
Google Scholar
Levine DA, Network TCGAR. Integrated genomic characterization of endometrial carcinoma. Nature. 2013;497:67–73.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lee S, Abecasis GR, Boehnke M, Lin X. Rare-Variant Association Analysis: Study Designs and Statistical Tests. Am J Human Genet. 2014;95:5–23.
Article
CAS
Google Scholar
Bell D, O'Hara. The genomics and genetics of endometrial cancer. AGG. 2012;2012(2):33–15.
Article
CAS
Google Scholar
Park S, Supek F, Lehner B. Systematic discovery of germline cancer predisposition genes through the identification of somatic second hits. Nat Commun. 2018;9:302–13.
Article
CAS
Google Scholar
Musgrove EA, Caldon CE, Barraclough J, Stone A, Sutherland RL. Cyclin D as a therapeutic target in cancer. Nature. 2011;11:558–72.
CAS
Google Scholar
Ikeda Y, Oda K, Ishihara H, Wada-Hiraike O, Miyasaka A, Kashiyama T, et al. Prognostic importance of CDK4/6-specific activity as a predictive marker for recurrence in patients with endometrial cancer, with or without adjuvant chemotherapy. Br J Cancer. 2015;113:1477–83.
Yen C-F, Liao S-K, Huang SJ, Tabak S, Arcuri F, Lee C-L, et al. Decreased endometrial expression of leukemia inhibitory factor receptor disrupts the STAT3 signaling in Adenomyosis during the implantation window. Reprod Sci. 2017;24:1176–86.
Article
CAS
PubMed
Google Scholar
Cheng J-G, Chen JR, Hernandez L, Alvord WG, Stewart CL. Dual control of LIF expression and LIF receptor function regulate Stat3 activation at the onset of uterine receptivity and embryo implantation. Proc Natl Acad Sci USA. 2001;98:8680–5.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bennett JA, Oliva E, Nardi V, Lindeman N, Ferry JA, Louissaint A. Primary endometrial marginal zone lymphoma (MALT lymphoma). Am J Surg Pathol. 2016;40:1217–23.
Article
PubMed
Google Scholar
Kastrinos F, Stoffel EM. History, genetics, and strategies for Cancer prevention in Lynch syndrome. Clin Gastroenterol Hepatol. 2014;12:715–27.
Article
CAS
PubMed
Google Scholar
Periyasamy M, Singh AK, Gemma C, Kranjec C, Farzan R, Leach DA, et al. p53 controls expression of the DNA deaminase APOBEC3B to limit its potential mutagenic activity in cancer cells. Nucleic Acids Res. 2017;45:11056–69.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chiu Y-L, Greene WC. The APOBEC3 Cytidine Deaminases: An Innate Defensive Network Opposing Exogenous Retroviruses and Endogenous Retroelements. Ann Rev. 2008;26:317–53. https://doi.org/10.1146/annurev.immunol.26.021607.090350.
Article
CAS
Google Scholar
Refsland EW, Harris RS. The APOBEC3 Family of Retroelement Restriction Factors. Intrinsic Immunity. Berlin: Springer, Berlin, Heidelberg; 2013. p. 1–27.
Book
Google Scholar
Srsen V, Gnadt N, Dammermann A, Merdes A. Inhibition of centrosome protein assembly leads to p53-dependent exit from the cell cycle. J Cell Biol. 2006;174:625–30.
Article
CAS
PubMed
PubMed Central
Google Scholar
Balczon R. PCM-1, a 228-kD centrosome autoantigen with a distinct cell cycle distribution. J Cell Biol. 1994;124:783–93.
Article
CAS
PubMed
Google Scholar
Reiter A, Walz C, Watmore A, Schoch C, Blau I, Schlegelberger B, et al. The t (8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2. Cancer Res. 2005;65:2662–7.
Article
CAS
PubMed
Google Scholar
Adelaide J, Perot C, Gelsi-Boyer V, Pautas C, Murati A, Copie-Bergman C, et al. A t (8;9) translocation with PCM1-JAK2 fusion in a patient with T-cell lymphoma. Leukemia. 2006;20:536–7.
Article
CAS
PubMed
Google Scholar
Segev Y, Iqbal J, Lubiński J, Gronwald J, Lynch HT, Moller P, et al. The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: an international prospective cohort study. Gynecol Oncol. 2013;130:127–31.
Article
CAS
PubMed
Google Scholar
Seroz T, Hwang JR, Moncollin V, Egly JM. TFIIH: a link between transcription, DNA repair and cell cycle regulation. Curr Opin Genet Dev. 1995;5:217–21.
Article
CAS
PubMed
Google Scholar
von Bergh ARM, Beverloo HB, Rombout P, van Wering ER, van Weel MH, Beverstock GC, et al. LAF4, an AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia. Genes Chromosomes Cancer. 2002;35:92–6.
Moore JM, Oliver PL, Finelli MJ, Lee S, Lickiss T, Molnár Z, et al. Laf4/Aff3, a Gene Involved in Intellectual Disability, Is Required for Cellular Migration in the Mouse Cerebral Cortex. PLoS ONE. 2014;9:e105933.
Article
CAS
PubMed
PubMed Central
Google Scholar
Dong X-Y, Guo P, Sun X, Li Q, Dong J-T. Estrogen up-regulates ATBF1 transcription but causes its protein degradation in estrogen receptor-alpha-positive breast cancer cells. J Biol Chem. 2011;286:13879–90.
Article
CAS
PubMed
PubMed Central
Google Scholar
Minamiya Y, Saito H, Ito M, Imai K, Konno H, Takahashi N, et al. Suppression of zinc finger Homeobox 3 expression in tumor cells decreases the survival rate among non-small cell lung cancer patients. Cancer Biomark. 2012;11:139–46.
Article
CAS
PubMed
Google Scholar
Huang S, Ernberg I, Kauffman S. Cancer attractors: a systems view of tumors from a gene network dynamics and developmental perspective. Semin Cell Dev Biol. 2009;20:869–76.
Article
CAS
PubMed
PubMed Central
Google Scholar